These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 14728591)
1. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen. Sinawat S; Chiyabutra T; Kleabkaew P Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591 [TBL] [Abstract][Full Text] [Related]
2. Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study. Sinawat S; Chiyabutra T J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S59-63. PubMed ID: 21218592 [TBL] [Abstract][Full Text] [Related]
3. Endometrial abnormalities in postmenopausal breast cancer patients. Sinawat S; Chiyabutra T; Kleabkaew P J Med Assoc Thai; 2004 Jun; 87(6):636-40. PubMed ID: 15279341 [TBL] [Abstract][Full Text] [Related]
4. Increased risk of endometrial abnormalities in breast cancer patients taking tamoxifen: the need for gynaecologic surveillance. Sinawat S; Chiyabutra T Asian Pac J Cancer Prev; 2004; 5(2):183-7. PubMed ID: 15244522 [TBL] [Abstract][Full Text] [Related]
5. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients. Kavak ZN; Binöz S; Ceyhan N; Pekin S Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963 [TBL] [Abstract][Full Text] [Related]
6. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
7. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen. Gao WL; Zhang LP; Feng LM Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294 [TBL] [Abstract][Full Text] [Related]
10. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen]. Reslová T; Tosner J; Vávrová I; Resl M Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168 [TBL] [Abstract][Full Text] [Related]
11. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report. Sinawat S; Chiyabutra T; Kleabkaew P J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963 [TBL] [Abstract][Full Text] [Related]
12. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients. Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946 [TBL] [Abstract][Full Text] [Related]
13. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow. Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941 [TBL] [Abstract][Full Text] [Related]
14. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF; Lin HH; Torng PL; Huang SC Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP Menopause; 2009; 16(2):293-300. PubMed ID: 19034048 [TBL] [Abstract][Full Text] [Related]
16. Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy. Ito T; Katagiri C; Murata Y; Hamazoe R; Morita K J Obstet Gynaecol Res; 2001 Jun; 27(3):141-5. PubMed ID: 11561830 [TBL] [Abstract][Full Text] [Related]
17. Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen. Ozşener S; Ozaran A; Itil I; Dikmen Y Eur J Gynaecol Oncol; 1998; 19(6):580-3. PubMed ID: 10215447 [TBL] [Abstract][Full Text] [Related]
18. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen. Elhelw B; Ghorab MN; Farrag SH Int J Gynaecol Obstet; 1999 Nov; 67(2):81-6. PubMed ID: 10636051 [TBL] [Abstract][Full Text] [Related]
19. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology. Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080 [TBL] [Abstract][Full Text] [Related]
20. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen. Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]